| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.013 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |